Arcadis: Large contract in Resilience. ASM International: Highlights from CFO roadshow. Exor: Exor buying back Exor shares. Fastned: 2H24 results, cost pressure. Flow Traders: February volumes elevated in EMEA. Montea: JV with Weerts in Belgium. Sligro: FY24 results in line, weak 1Q25 outlook. Sofina: Final NAV a tad higher. Umicore: CMD targets – no big bang
During FY24, NAV rose by 9% YoY to €38.2b or €178.8ps (KBCSe: €174.3ps). This was mainly driven by the rally in Ferrari (35%+) and Philips (16%+). Exor has been diversifying its portfolio away from Ferrari, its single biggest position, which currently makes up ~40% of NAV. During FY24, Exor increased its stake in Philips to 18.7%, acquired a 10.1% stake in Clarivate, increased stake in Institut Mérieux to 10% and executed a €72m follow up investment in TagHolding. Furthermore, during March'25, E...
Exor Press Release - Tender Offer Launch THIS PRESS RELEASE IS NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN AUSTRALIA, CANADA, JAPAN, OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION WOULD BE PROHIBITED BY APPLICABLE LAW. Amsterdam, 26 March 2025 EXOR ANNOUNCES THE LAUNCH OF A TENDER OFFER TO REPURCHASE UP TO €1 BILLION IN ORDINARY SHARES Exor N.V. (“Exor” or the “Company”) announces the launch of a tender offer to purchase ordinary shares with a nominal value of EUR 0.01 each in the share capital of Exor N...
Exor Press Release - FY24 Results Amsterdam, 26 March 2025 EXOR DELIVERS 9% NAV PER SHARE GROWTH IN 2024 LAUNCH OF A €1 BILLION SHARE BUYBACK PROGRAM WITH TENDER OFFER AT UP TO 10% PREMIUM NAV reached €38.2 billion at 31 December 2024, with NAV per share increasing by 9%Strong cash flow generation with dividends received from companies and asset disposals amounting to €1.5 billion in 2024. Active and disciplined capital allocation with increased exposure to Healthcare Ordinary dividend to be distributed of approximately €100 million, subject to AGM approvalLaunch of a new €1 billion sh...
1M Performance - Absolute: During Feb'25 (1M period), the KBCS Holdings Universe posted a return of +3.7% which was mainly driven by single-asset holdings (+11.1%) while multi-asset holdings posted a modest return of +0.5%. The 3 top performers during the period were Heineken Holding (+21.3%), KBC Ancora (+6.9%) and Ackermans & van Haaren (+4.4%) while the 3 worst performers were Financière de Tubize (-6.3%), Compagnie du Bois Sauvage (TINC; -6.6%) and Whitestone Group (-6.8%). YTD Performance...
Exor announced that it will sell ~6.7m common shares (3.61% of total shares) of Ferrari, via an accelerated bookbuild offering to institutional investors, for total proceeds of ~€3.0b. The shares are being offered at €450.0ps and the transaction is expected to be completed by 3rd March'25. Post transaction, Exor's stake in Ferrari will decline from 22.91% to 19.47%. Exor guided that the proceeds will be used to introduce a new investment withing the portfolio and execute a €1.0b SBB program. Whi...
Aalberts: Dividend and outlook better than expected. Ackermans & van Haaren: Anticipating an all-time-high result from core segments. Ageas: FY24 in line, strong capital, outlook for upsteams. AMG: Strong 4Q24 beat and 2025F guidance upgrade. CFE: Solid results and balance sheet, outlook weak. CMB.TECH: Cautious on outlook. Corbion: Not so sweet. CTP: Good results, 2025 outlook realistic. D'Ieteren: Boyd's Five-Year Goals. Exor: Ferrari €3bn ABB and €1bn SBB. Sofina: Further ...
Correction: Exor Press Release - ABO Pricing Amsterdam, 27 February 2025 EXOR ANNOUNCES THE SUCCESSFUL PRICING OF THE ACCELERATED BOOKBUILD OFFERING FOR APPROXIMATELY 4% OF FERRARI’S OUTSTANDING SHARES Exor N.V. (“Exor”) announces the successful pricing of the previously announced accelerated bookbuild offering involving the sale of approximately 7 million common shares of Ferrari N.V. (“Ferrari”) (representing approximately 4% of the outstanding common shares of Ferrari) to institutional investors (the “Offering”) for total proceeds of €3 billion. Following completion of the transac...
Exor Press Release - ABO Launch Amsterdam, 27 February 2025 EXOR ANNOUNCES THE SUCCESSFUL PRICING OF THE ACCELERATED BOOKBUILD OFFERING FOR APPROXIMATELY 4% OF FERRARI’S OUTSTANDING SHARES Exor N.V. (“Exor”) announces the successful pricing of the previously announced accelerated bookbuild offering involving the sale of approximately 7 million common shares of Ferrari N.V. (“Ferrari”) (representing approximately 4% of the outstanding common shares of Ferrari) to institutional investors (the “Offering”) for total proceeds of €3 billion. Following completion of the transaction, Exor wi...
Exor Press Release - ABO Launch Amsterdam, 26 February 2025 EXOR ANNOUNCES THE LAUNCH OF AN ACCELERATED BOOKBUILD OFFERING FOR APPROXIMATELY 4% OF FERRARI’S OUTSTANDING SHARES Exor remains fully committed to supporting Ferrari’s strategy as well as remaining its largest shareholder for the long-term No changes in Ferrari’s governance structure following the transactionThe transaction will reduce concentration within Exor’s portfolio. Sale proceeds of approximately €3 billion are intended to be used to pursue diversification through a sizeable new acquisition and to launch a new share buyb...
1M Performance - Absolute: During Jan'25 (1M period), the KBCS Holdings Universe posted a return of +3.1% which was mainly driven by multi-asset holdings (+3.3%) while single-asset holdings posted a slightly lower return of +2.7%. The 3 top performers during the period were Sofina (+10.6%), Financière de Tubize (+7.5%) and Whitestone Group (+6.4%) while the 3 worst performers were Gimv (-2.0%), The Infrastructure Company (TINC; -3.4%) and Texaf (-5.1%). YTD Performance - Relative: On a YTD bas...
Exor Press Release - 2025 Corporate Calendar Amsterdam, 31 January 2025 EXOR N.V. PUBLISHES ITS 2025 CORPORATE CALENDAR EXOR N.V. announced today the following Corporate Calendar for 2025: 26 March 2025: Board of Directors Meeting for the approval of the Company’s 2024 Annual Report22 May 2025: Annual General Meeting of Shareholders for the adoption of the Company’s 2024 Financial Statements17 September 2025: Board of Directors Meeting for the approval of the Company’s 2025 Half-Year Financial Report The 2025 Corporate Calendar will be available on Exor’s corporate website under the ...
1M Performance - Absolute: During Dec'24 (1M period), the KBCS Holdings Universe posted a return of -3.2% which was mainly driven by multi-asset holdings (-4.3%) while single-asset holdings posted a significantly less negative return of -0.6%. The 3 top performers during the period were D'Ieteren Group (+26.6%), Compagnie du Bois Sauvage (+7.0%) and KBC Ancora (+7.0%) while the 3 worst performers were Exor (-5.4%), Heineken Holding (-3.6%) and Gimv (-1.1%). FY24 Performance - Relative: During ...
1M Performance - Absolute: During Nov'24 (1M period), the KBCS Holdings Universe posted a return of -3.6% which was mainly driven by single-asset holdings (-6.9%) while multi-asset holdings posted a slightly less negative return of -2.2%. The 3 top performers during the period were D'Ieteren Group (+5.4%), Gimv (+5.1%) and KBC Ancora (+0.6%) while the 3 worst performers were Compagnie du Bois Sauvage (-10.1%), Heineken Holding (-9.6%) and Quest For Growth (-7.5%). YTD Performance - Relative: O...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.